Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating these https://sahilepwd484210.bligblogging.com/36948755/retatrutide-a-promising-new-treatment-for-obesity